Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib and Tositumomab I-131 in Relapsed/Refractory Follicular Lymphoma
NCT00479167Phase 2Terminated
- Sponsor
- Rush University Medical Center
- Start
- May 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in follicular lymphoma (FL), sponsored by Rush University Medical Center. Started May 2007; status: terminated.
02
Drugs
bortezomib
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00479167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00479167.